Last reviewed · How we verify

NCT07161648

Use of Neuromuscular Electrical Stimulation to Prevent Exercise Resistance

Recruiting now NA Last updated 14 November 2025
What this trial tests

NA trial testing neuromuscular electrical stimulation in Fat Metabolism in 30 participants. Currently enrolling.

Timeline
17 October 2024
Primary endpoint
30 September 2026
30 September 2026

Quick facts

Lead sponsorColorado State University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment30
Start date17 October 2024
Primary completion30 September 2026
Estimated completion30 September 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Colorado State University

Who can join

Adults 18 to 40, any sex, with Fat Metabolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will find out if 100 minutes of electrical stimulation of muscle prevents the unfavorable consequence of insufficient exercise.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of neuromuscular electrical stimulation

Trials testing the same drug.

Other Colorado State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07161648.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing